- Home
- LUNG vs AIRS Comparison
LUNG vs AIRS Comparison
Compare LUNG & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- AIRS
- Stock Information
- Founded
- LUNG 1995
- AIRS 2012
- Country
- LUNG United States
- AIRS United States
- Employees
- LUNG N/A
- AIRS N/A
- Industry
- LUNG Industrial Specialties
- AIRS Medical/Nursing Services
- Sector
- LUNG Health Care
- AIRS Health Care
- Exchange
- LUNG Nasdaq
- AIRS Nasdaq
- Market Cap
- LUNG 106.3M
- AIRS 166.3M
- IPO Year
- LUNG 2020
- AIRS 2021
- Fundamental
- Price
- LUNG $2.78
- AIRS $5.12
- Analyst Decision
- LUNG Buy
- AIRS Hold
- Analyst Count
- LUNG 6
- AIRS 3
- Target Price
- LUNG $11.53
- AIRS $3.75
- AVG Volume (30 Days)
- LUNG 327.3K
- AIRS 547.0K
- Earning Date
- LUNG 07-30-2025
- AIRS 08-08-2025
- Dividend Yield
- LUNG N/A
- AIRS N/A
- EPS Growth
- LUNG N/A
- AIRS N/A
- EPS
- LUNG N/A
- AIRS N/A
- Revenue
- LUNG $87,473,000.00
- AIRS $172,101,000.00
- Revenue This Year
- LUNG $18.02
- AIRS N/A
- Revenue Next Year
- LUNG $18.17
- AIRS $4.90
- P/E Ratio
- LUNG N/A
- AIRS N/A
- Revenue Growth
- LUNG 19.84
- AIRS N/A
- 52 Week Low
- LUNG $2.50
- AIRS $1.53
- 52 Week High
- LUNG $9.37
- AIRS $9.20
- Technical
- Relative Strength Index (RSI)
- LUNG 42.03
- AIRS 55.70
- Support Level
- LUNG $2.58
- AIRS $4.75
- Resistance Level
- LUNG $3.09
- AIRS $5.65
- Average True Range (ATR)
- LUNG 0.20
- AIRS 0.38
- MACD
- LUNG 0.04
- AIRS -0.05
- Stochastic Oscillator
- LUNG 26.93
- AIRS 47.00
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.